Akram Seifollahi

Akram Seifollahi

Auto-generated profile, based on publicly available information

Akram Seifollahi

Department of Pathology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2014 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
SASadaf Alipour
Sadaf Alipour
ASAzin Saberi
Azin Saberi
ASAkram Seifollahi
Akram Seifollahi
NSNooshin Shirzad
Nooshin Shirzad
LHLadan Hosseini
Ladan Hosseini
Background: Several studies indicated that there is a high prevalence of vitamin D deficiency in Middle East countries. Objectives: The aim of this study was to determine the prevalence and assess some risk factors of vitamin D deficiency among women attending our clinics in Tehran, the capital of Iran. Patients and Methods: Five hundred and thirty-eight women aged 20-80 years were entered in this cross-sectional study from 2011 to 2012. Serum 25-hydroxy vitamin D levels were measured in all participants after recruiting their demographic and anthropometric data and past medical histories. Deficiency was defined as levels less than 35 nmol/L and classified as mild (≥ 25 nmol/L), moderate (12.5-25 nmol/L) and severe (≤ 12.5 nmol/L). Results: The prevalence of vitamin D deficiency was 69%; mild, moderate and severe degrees were seen in %10.4, %38.3, and %20.3 respectively. Analysis of logistic regression shows that age (OR:0.96, CI: 0.93-0.97), menopause (OR: 0.44, CI: 0.21-0.99) and consumption of multivitamin supplements (OR: 2.67, CI: 1.4-5) were independent predictive factors for Vitamin D deficiency. Conclusions: This study showed a high prevalence of vitamin D deficiency among Iranian women especially in reproductive ages. Keywords: Vitamin D; Deficiency; Prevalence; Iran

1 February 2024 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
RORamesh Omranipour
Ramesh Omranipour
FAFatemeh Ahmadi-Harchegani
Fatemeh Ahmadi-Harchegani
ASAzin Saberi
Azin Saberi
AMAshraf Moini
Ashraf Moini
MSMostafa Shiri
Mostafa Shiri
SASadaf Alipour
Sadaf Alipour
Background: Breast cancer (BC) treatment decreases fertility capacity, but unnecessary fertility preservation procedures in women who would not be infertile after treatment would be a waste of time and resources and could cause the unwarranted exposure of cancer cells to exogenous sex hormones. It has been largely shown that post-treatment ovarian reserve is directly associated with pre-treatment anti-mullerian hormone levels (AMH0). A threshold for AMH0, or a model including AMH0 and patient characteristics that could distinguish the patients who will be infertile after treatments, still needs to be defined. Accordingly, this study was performed to specifically target this high-priority concern. Methods: Women≤45 years old with newly diagnosed non-metastatic BC were entered in this multicenter prospective cohort study. AMH0 and two-year post-treatment AMH (AMH2) were measured, and hormonal patient features were recorded as well. Receiver operating characteristic (ROC) curve analysis, decision tree (DT), and random forest analyses were performed to find a cut-off point for AMH0 and define a model involving related features for the prediction of AMH2. Results: The data from 84 patients were analyzed. ROC curve analysis revealed that AMH0>3 ng/mL (Area under the curve=0.69, 95% CI: 0.54‒0.84) was the best indicator for predicting AMH2≥0.7 (sensitivity=79%, specificity=60%). The best model detected by DT and random forest for predicting an AMH2>0.7 with a probability of 93% consisted of a combination of AMH0>3.3, menarche age<14, and age<31. Conclusion: This combination model can be used to withhold fertility preservation procedures in BC patients. Performing larger studies is suggested to further test this model.

1 March 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
SKSara Kasraei
Sara Kasraei
AGAkram Ghahghaei-Nezamabadi
Akram Ghahghaei-Nezamabadi
ASAkram Seifollahi
Akram Seifollahi
FAFaezeh Aghajani
Faezeh Aghajani
ANAmin Nakhostin-Ansari
Amin Nakhostin-Ansari
ATAfsaneh Tehranian
Afsaneh Tehranian

1 August 2023 in Journal of Clinical Ultrasound
Verified
Journal Article
Open access
FKFatemeh Shakki Katouli
Fatemeh Shakki Katouli
LBLeila Bayani
Leila Bayani
FAFahimeh Azizinik
Fahimeh Azizinik
SFSomayeh Fathi
Somayeh Fathi
ASAkram Seifollahi
Akram Seifollahi
FBFatemeh Zare Bozorgabadi
Fatemeh Zare Bozorgabadi
Breast conservative treatment (BCT) is currently accepted as the standard treatment option for breast cancer. Targeted ultrasound helps detect recurrent lesions, postoperative changes, and scarring tissue. In this pictorial essay, we review the ultrasound features of benign (seroma, hematoma, fat necrosis, traumatic neuroma, fibrosis/scarring) and malignant (recurrence, new primary cancer) causes of palpable lumps after BCT and provide images from our patients to illustrate some typical findings of common pathologies. Ultrasound, especially as an adjunct to mammography, can make a specific diagnosis in most cases.

6 March 2024 in Disease and Diagnosis
Verified
Journal Article
Open access
PDF file
LKLadan Kashani
Ladan Kashani
AKAtefeh Khezri
Atefeh Khezri
ASAkram Seifollahi
Akram Seifollahi
ZGZahra Gharibi
Zahra Gharibi
Background: Pregnancy in the rudimentary horn of the unicornuate uterus is highly rare. Its incidence is 1 in 75000-150000 pregnancies. It is difficult to diagnose the rudimentary horn of the unicornuate uterus before the rupture of an ectopic pregnancy. Case Presentation: The current study reports the case of a 35-year-old Iranian mother with a natural contraceptive method. The mother was a primigravida woman at the gestational age of 7 weeks, based on her last period. She complained of abdominal pain in the right and lower abdomen and had a positive pregnancy test with a beta-human chorionic gonadotropin beta-human chorionic gonadotropin (beta-hCG) titration of 38982 on May 17, 2021. The ultrasound report on May 17, 2021, showed a right adnexal mass with a size of 32*32*31 and a fetal pole, and yolk sac. A fetal heart of six weeks and one day in favor of ectopic pregnancy was detected. and its endometrial thickness was 12 mm. There were no abdominal or pelvic-free fluids. Thus, after being diagnosed with an ectopic pregnancy that included a heart, the patient was transferred to the operating room for laparoscopy. During laparoscopy, we found that the pregnancy was in the rudimentary horn of the unicornuate uterus. The rudimentary horn was resected, and the salpingectomy of the right side was performed for the patient. The samples were then transferred to the laboratory for pathological analysis. Conclusion: We should increase awareness about pregnancies that occur in this uterine abnormality so that there is a high suspicion index for faster diagnosis before the rupture of ectopic pregnancy and worse events can be prevented accordingly.